494 related articles for article (PubMed ID: 26100991)
61. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
62. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
63. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
[TBL] [Abstract][Full Text] [Related]
64. Refractory T cell acute lymphoblastic leukemia with unusual karyotype and interesting immunophenotype.
Anreder MB; Mitruka BM; Gill J; Varela M; Rozans MK; Krause JR
J La State Med Soc; 1996 Dec; 148(12):521-4. PubMed ID: 8990795
[TBL] [Abstract][Full Text] [Related]
65. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
66. The immunophenotype of adult T acute lymphoblastic leukemia in Morocco.
Lahjouji A; Bachir F; Bennani S; Quessar A; Amzazi S
Exp Oncol; 2015 Mar; 37(1):64-9. PubMed ID: 25804235
[TBL] [Abstract][Full Text] [Related]
67. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.
Czuczman MS; Dodge RK; Stewart CC; Frankel SR; Davey FR; Powell BL; Szatrowski TP; Schiffer CA; Larson RA; Bloomfield CD
Blood; 1999 Jun; 93(11):3931-9. PubMed ID: 10339502
[TBL] [Abstract][Full Text] [Related]
68. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias.
Lai R; Juco J; Lee SF; Nahirniak S; Etches WS
Am J Clin Pathol; 2000 Jun; 113(6):823-30. PubMed ID: 10874883
[TBL] [Abstract][Full Text] [Related]
69. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
70. [The expression of CD19 in 210 cases of childhood acute leukemia and its significance].
Chen YH; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Qian BQ; Xu WQ; Ning BT
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):188-91. PubMed ID: 15144712
[TBL] [Abstract][Full Text] [Related]
71. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Shuster JJ; Falletta JM; Pullen DJ; Crist WM; Humphrey GB; Dowell BL; Wharam MD; Borowitz M
Blood; 1990 Jan; 75(1):166-73. PubMed ID: 1688495
[TBL] [Abstract][Full Text] [Related]
72. [Immunophenotyping characteristics of biphenotypic acute leukemia and analysis of curative effect].
Zhang JJ; Zhang N; Zhang XF; Shi Y; Wang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):317-20. PubMed ID: 21518479
[TBL] [Abstract][Full Text] [Related]
73. The relationship between argyrophilic proteins and some immunophenotypic markers in acute leukemia cells.
Klobusická M; Babusíková O
Neoplasma; 1997; 44(6):356-60. PubMed ID: 9605007
[TBL] [Abstract][Full Text] [Related]
74. Association of immunophenotype with cerebrospinal fluid involvement in childhood B-lineage acute lymphoblastic leukemia.
Donskoy E; Tausche F; Altman A; Quinn J; Goldschneider I
Am J Clin Pathol; 1997 May; 107(5):608-16. PubMed ID: 9128275
[TBL] [Abstract][Full Text] [Related]
75. A case of CD45-, CD19- precursor B cell acute lymphoblastic leukemia with an atypical morphology.
Moon H; Huh J; Cho MS; Chi H; Chung WS
Korean J Lab Med; 2007 Aug; 27(4):253-6. PubMed ID: 18094585
[TBL] [Abstract][Full Text] [Related]
76. Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens.
Toth B; Wehrmann M; Kaiserling E; Horny HP
J Clin Pathol; 1999 Sep; 52(9):688-92. PubMed ID: 10655992
[TBL] [Abstract][Full Text] [Related]
77. [Application of flow cytometry in the differential diagnosis of lymphoma/leukemia with aberrant antigen expression].
Xia CQ; Chen SL; Qi M; Xu XF
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):532-5. PubMed ID: 15634450
[TBL] [Abstract][Full Text] [Related]
78. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.
Cheng J; Klairmont MM; Choi JK
Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571
[TBL] [Abstract][Full Text] [Related]
79. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: A study from Northern India.
Sharma M; Sachdeva MU; Varma N; Varma S; Marwaha RK
J Cancer Res Ther; 2016; 12(2):620-6. PubMed ID: 27461621
[TBL] [Abstract][Full Text] [Related]
80. [Application of a four antibody (cMPO/cCD79aalpha/cCD3/CD45) combination to the diagnosis of acute leukemia expressing cross-lineage antigens].
Wu YJ; Li JY; Zhu MQ; Song JH; Zheng WJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):449-51. PubMed ID: 17147246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
